BioSpace News Archive

Bristol Myers Squibb will take part in a fireside chat at the 41st Annual Goldman Sachs Global Healthcare Conference, which will be webcast on June 11, 2020.

Varex Imaging, Corp. announced that it intends to offer $150 million aggregate principal amount of its Convertible Senior Notes due 2025 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Transit Scientific announced the FDA cleared the XO Score® Percutaneous Transluminal Angioplasty Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal, and renal arterial plus synthetic and/or native arteriovenous hemodialysis fistula.

Following meetings with both the U.S. FDA and EMA, Can-Fite is ready to submit its protocol and conduct one pivotal trial for registration in both markets

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that it has submitted requests to Polish regulatory authorities for a

Athira Pharma, Inc., a clinical-stage company developing innovative first-in-class regenerative therapies with the potential to restore brain function, today announced the closing of an $85 million Se

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF), a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced it is collaborating, pursuant to an agreement dated May 14, 2020 , in a multi-company effort with the laboratory of Dr. Fr

Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a development and license agreement with Medtronic plc (“Medtronic”) (NYSE: MDT) to further the development of robotic assisted surgical technologies, as well as a separate license agreement with Medtronic in respe

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold its 2020 annual meeting of stockholders in a virtual-only format due to health and safety concerns related to the ongoing COVID-19 pandemic and to comply with federal, state, and local restrictions on public gatherings. Stockholders will not be able to attend the annual meeting in person. The time and date of

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will participate in a fireside chat at the virtual Goldman Sachs 41 st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 11:20am ET. A live audio webcast of the fireside chat will be available on the Investors & Media section of Pas